The drug Zolgensma has been registered in Russia for the treatment of spinal muscular atrophy
The drug Zolgensma has been registered in Russia for the treatment of spinal muscular atrophy (SMA), according to the state register of medicines. to this . drew attention The head of the SMA Families Foundation, Olga Germanenko, In a conversation with Novaya Gazeta, she clarified that usually, after registration, drugs become available within two to six months. “Based on the experience of drugs for spinal muscular atrophy, manufacturing companies met approximately this deadline.